Challenges in the Long-term Management of Patients With Coccidioidal Meningitis: A Retrospective Analysis of

Geetha Sivasubramanian1, Saurin Kadakia2, Jani M Kim1

  • 1Division of Infectious Disease, University of California, San Francisco, Fresno, California, USA.

PubMed
Abstract

Insights

Coccidioidal meningitis (CM) treatment is challenging, with high rates of antifungal nonadherence and shunt failures. Addressing patient barriers to care is crucial for improving outcomes in this severe fungal infection.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Public Health

Background:

  • Coccidioidal meningitis (CM) is the most severe form of disseminated coccidioidomycosis.
  • Treatment is difficult, often requiring surgery and lifelong antifungal therapy.

Purpose of the Study:

  • To analyze treatment outcomes and challenges in Coccidioidal meningitis (CM) patients.
  • To identify factors associated with mortality and treatment failure.

Main Methods:

  • Retrospective analysis of 133 Coccidioidal meningitis (CM) patients from 2010-2020 in Central Valley, California.
  • Data collected on antifungal adherence, surgical interventions, rehospitalizations, and mortality.

Main Results:

  • 43% of patients were nonadherent to antifungal therapy.
  • 52.5% of shunt placements required revision surgery.
  • 23% of patients died, with encephalopathy at presentation increasing mortality risk.

Conclusions:

  • CM patients in Central California face socioeconomic barriers impacting adherence and follow-up.
  • High rates of treatment failure, rehospitalization, and surgical complications are observed.
  • Overcoming barriers to care and developing new antifungal agents are essential for improving CM management.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
199
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
16
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
399
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K